<?xml version="1.0" encoding="UTF-8"?>
<tns:CompleteTrialRegistration xmlns:tns="gov.nih.nci.pa.webservices.types"
	xmlns:tns1="gov.nih.nci.po.webservices.types.trimmed" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="gov.nih.nci.pa.webservices.types ../../src/resources/ws.xsd ">
	
	<tns:clinicalTrialsDotGovXmlRequired>true</tns:clinicalTrialsDotGovXmlRequired>
	<tns:leadOrgTrialID>UPCC 34890534</tns:leadOrgTrialID>
	<tns:clinicalTrialsDotGovTrialID>NCT01994850</tns:clinicalTrialsDotGovTrialID>
	<tns:otherTrialID>818280234</tns:otherTrialID>
	<tns:title>A Phase I/II Study Of Brentuximab Vedotin In Combination With Multi-Agent Chemotherapy</tns:title>
	<tns:phase>I</tns:phase>
	<tns:pilot>false</tns:pilot>
	<tns:accrualDiseaseTerminology>ICD10</tns:accrualDiseaseTerminology>
	<tns:primaryPurpose>Other</tns:primaryPurpose>
	<tns:primaryPurposeOtherDescription>Determine maximum tolerated dose (MTD) of brentuximab vedotin</tns:primaryPurposeOtherDescription>
	<tns:interventionalDesign>
		<tns:secondaryPurpose>Other</tns:secondaryPurpose>
		<tns:secondaryPurposeOtherDescription>Secondary Other Description</tns:secondaryPurposeOtherDescription>
	</tns:interventionalDesign>
	<tns:leadOrganization>
		<tns:existingOrganization>
			<tns:poID>1</tns:poID>
		</tns:existingOrganization>
	</tns:leadOrganization>
	<tns:pi>
		<tns:existingPerson>
			<tns:poID>1</tns:poID>
		</tns:existingPerson>
	</tns:pi>
	<tns:sponsor>
		<tns:existingOrganization>
			<tns:poID>2</tns:poID>
		</tns:existingOrganization>
	</tns:sponsor>
	<tns:responsibleParty>
		<tns:type>Sponsor</tns:type>
	</tns:responsibleParty>
	<tns:summary4FundingSponsor>
		<tns:existingOrganization>
			<tns:poID>3</tns:poID>
		</tns:existingOrganization>
	</tns:summary4FundingSponsor>
	<tns:programCode>PG00001</tns:programCode>
	<tns:fundedByNciGrant>false</tns:fundedByNciGrant>
	<tns:grant>
		<tns:fundingMechanism>B09</tns:fundingMechanism>
		<tns:nihInstitutionCode>AA</tns:nihInstitutionCode>
		<tns:serialNumber>111111</tns:serialNumber>
		<tns:nciDivisionProgramCode>CCR</tns:nciDivisionProgramCode>
		<tns:fundingPercentage>100.0</tns:fundingPercentage>
	</tns:grant>
	<tns:trialStatus>In Review</tns:trialStatus>
	<tns:whyStopped></tns:whyStopped>
	<tns:trialStatusDate>2014-07-15</tns:trialStatusDate>
	<tns:trialStartDate type="Actual">2014-07-15</tns:trialStartDate>
	<tns:primaryCompletionDate type="Anticipated">2018-07-15</tns:primaryCompletionDate>
	<tns:completionDate type="Anticipated">2018-07-15</tns:completionDate>
	<tns:ind>
		<tns:number>111111</tns:number>
		<tns:grantor>CDER</tns:grantor>
		<tns:holderType>NIH</tns:holderType>
		<tns:nihInstitution>NEI</tns:nihInstitution>
		<tns:expandedAccess>true</tns:expandedAccess>
		<tns:expandedAccessType>Available</tns:expandedAccessType>
		<tns:exempt>true</tns:exempt>
	</tns:ind>
	<tns:ide>
		<tns:number>222222</tns:number>
		<tns:grantor>CDRH</tns:grantor>
		<tns:holderType>NCI</tns:holderType>
		<tns:nciDivisionProgramCode>CCR</tns:nciDivisionProgramCode>
		<tns:expandedAccess>true</tns:expandedAccess>
		<tns:expandedAccessType>Available</tns:expandedAccessType>
		<tns:exempt>true</tns:exempt>
	</tns:ide>
	<tns:regulatoryInformation>
		<tns:country>USA</tns:country>
		<tns:authorityName>Federal Government</tns:authorityName>
		<tns:fdaRegulated>true</tns:fdaRegulated>
		<tns:section801>true</tns:section801>
		<tns:delayedPosting>true</tns:delayedPosting>
		<tns:dataMonitoringCommitteeAppointed>true</tns:dataMonitoringCommitteeAppointed>
	</tns:regulatoryInformation>
	<tns:protocolDocument filename="protocol.pdf">dGVzdA==</tns:protocolDocument>
	<tns:irbApprovalDocument filename="irb.pdf">dGVzdA==</tns:irbApprovalDocument>
	<tns:participatingSitesDocument
		filename="sites.pdf">dGVzdA==</tns:participatingSitesDocument>
	<tns:informedConsentDocument filename="consent.pdf">dGVzdA==</tns:informedConsentDocument>
	<tns:otherDocument filename="other.pdf">dGVzdA==</tns:otherDocument>
	<tns:category>Externally Peer-Reviewed</tns:category>	
</tns:CompleteTrialRegistration>
